Cytomegalovirus infection screening

Cytomegalovirus infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cytomegalovirus infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cytomegalovirus infection screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cytomegalovirus infection screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cytomegalovirus infection screening
CDC on Cytomegalovirus infection screening
Cytomegalovirus infection screening in the news
Blogs on Cytomegalovirus infection screening
Directions to Hospitals Treating Cytomegalovirus infection
Risk calculators and risk factors for Cytomegalovirus infection screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.

Screening

All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.